Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
clinical trials
life sciences
national blog main
fda
biotech
amgen
boston blog main
boston top stories
national
national top stories
new york blog main
abbvie
detroit blog main
detroit top stories
eli lilly
europe blog main
new york top stories
parkinson's disease
paul matteis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abaloparatide
acorda therapeutics
acute hepatic porphyrias
akin akinc
alder biopharmaceuticals
allergan
alnylam pharmaceuticals
aminolevulinic acid
ampyra
apokyn
apomorphine
bempedoic acid
bial
bigdata
biohaven
boston
boulder/denver blog main
What
nod
8
×
fda
drug
approval
approved
gets
medicine
medicines
new
pill
wins
amgen
class
developed
disease
migraine
parkinson’s
patients
second
treatment
acorda
add
adults
ago
allergan
alnylam
amgen’s
article
called
candidates
carbidopa
carries
cholesterol
combination
combo
control
cope
daily
demo
episodes
Language
unset
Current search:
nod
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@IainLJBrown
6 years ago
'Article of the Year' nod to demo of machine learning for personalized medicine Read more here: https://ift.tt/2HcK4oJ #MachineLearning #ML #DataScience #DeepLearning #NLP #Robots #AI #IoT #BigData